Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/11/2024 | Sector Weight | KeyBanc Capital Markets | |
| 4/25/2024 | $70.00 | Sell → Hold | Deutsche Bank |
| 3/6/2024 | $100.00 | Overweight | Barclays |
| 4/21/2023 | $83.00 | Neutral | Cantor Fitzgerald |
| 4/20/2023 | $75.00 → $63.00 | Hold → Sell | Deutsche Bank |
| 12/12/2022 | $90.00 → $95.00 | Hold → Buy | Loop Capital |
| 6/17/2022 | $72.00 | Hold | Loop Capital |
| 3/2/2022 | $74.00 → $78.00 | Outperform | Credit Suisse |
8-K - Acadia Healthcare Company, Inc. (0001520697) (Filer)
10-Q - Acadia Healthcare Company, Inc. (0001520697) (Filer)
8-K - Acadia Healthcare Company, Inc. (0001520697) (Filer)
Provides Updated Guidance for 2024 Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced financial results for the third quarter and nine months ended September 30, 2024. Third Quarter Highlights Revenue totaled $815.6 million, an increase of 8.7% over the third quarter of 2023 Same facility revenue increased 8.6% compared with the third quarter of 2023, including an increase in revenue per patient day of 3.6% and an increase in patient days of 4.7% Net income attributable to Acadia totaled $68.1 million, or $0.74 per diluted share Adjusted income attributable to Acadia totaled $84.1 million, or $0.91 per diluted share Adjusted EBITDA totaled $194.3 million, an increase
Clinics are the Company's first opioid use disorder treatment centers in the Palmetto State Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced the acquisition of three opioid treatment program clinics in South Carolina, which provide treatment for people seeking recovery from opioid use disorder. The clinics – formerly the opioid treatment programs of Recovery Concepts, Recovery Concepts of the Carolina Upstate, and Clear Skye Treatment Center – will be rebranded within Acadia's Comprehensive Treatment Center (CTC) service line as Clinton Comprehensive Treatment Center, Easley Comprehensive Treatment Center, and Ridgeland Comprehensive Treatment Center. These facilities are th
Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced that it will release its third quarter 2024 results on Wednesday, October 30, 2024, after the close of the market. Acadia will conduct a conference call with institutional investors and analysts at 9:00 a.m. ET on Thursday, October 31, 2024. A live broadcast of the conference call will be available at www.acadiahealthcare.com in the "Investors" section of the website. The webcast of the conference call will be available for 30 days. About Acadia Healthcare Acadia is a leading provider of behavioral healthcare services across the United States. As of June 30, 2024, Acadia operated a network of 258 behavioral healthcare facilitie
SC 13G/A - Acadia Healthcare Company, Inc. (0001520697) (Subject)
SC 13G/A - Acadia Healthcare Company, Inc. (0001520697) (Subject)
SC 13G/A - Acadia Healthcare Company, Inc. (0001520697) (Subject)
Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced the opening of its newest acute care hospital, Agave Ridge Behavioral Hospital, located at 3322 S. Ellsworth Road, in Mesa, Arizona. A ribbon-cutting ceremony was held today to mark its grand opening. The first patient admissions are expected to follow in the coming days as the hospital completes its final preparations to provide care for those in need. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240411986178/en/Acadia Healthcare hosts ribbon-cutting ceremony on April 11, 2024, for its new behavioral health hospital in Mesa, Arizona. The new hospital, named Agave R
Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced the appointment of Dr. Stephanie Eken as the Company's new chief medical officer. Dr. Eken is a psychiatrist with more than two decades of experience across the spectrum of behavioral health. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240404108920/en/Acadia Healthcare Appoints Dr. Stephanie Eken as Chief Medical Officer (Photo: Business Wire) "Acadia is thrilled to welcome Dr. Eken as our new chief medical officer," said Chris Hunter, Chief Executive Officer of Acadia Healthcare. "Her experience and expertise will help Acadia set the standard for care across the i
Henry Ford Health, one of the nation's premier academic and integrated health systems, and Acadia Healthcare, the nation's largest stand-alone behavioral healthcare company, today announced the appointment of Emily Sexton as Chief Executive Officer of Henry Ford Behavioral Health Hospital, the new 192-bed inpatient behavioral health hospital being built through a joint venture partnership between Henry Ford and Acadia in West Bloomfield, Michigan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240220715559/en/Henry Ford Health and Acadia Healthcare announced the appointment of Emily Sexton as Chief Executive Officer of Henry For
KeyBanc Capital Markets initiated coverage of Acadia Healthcare with a rating of Sector Weight
Deutsche Bank upgraded Acadia Healthcare from Sell to Hold and set a new price target of $70.00
Barclays initiated coverage of Acadia Healthcare with a rating of Overweight and set a new price target of $100.00
Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced that the Company will participate in the Stephens Annual Investment Conference, November 19 – 21, 2024, in Nashville, Tennessee. In connection with the conference, there will be an online webcast of the Company's presentation available on the Company's website starting at 11:00 a.m. Eastern Time / 10:00 a.m. Central Time on Wednesday, November 20, 2024. The live webcast of the presentation will be available on the Company's website, www.acadiahealthcare.com, by clicking on the "Investors" link. A replay of the presentation will also be available on the Company's website for 30 days. About Acadia Acadia is a leading provid
Provides Updated Guidance for 2024 Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced financial results for the third quarter and nine months ended September 30, 2024. Third Quarter Highlights Revenue totaled $815.6 million, an increase of 8.7% over the third quarter of 2023 Same facility revenue increased 8.6% compared with the third quarter of 2023, including an increase in revenue per patient day of 3.6% and an increase in patient days of 4.7% Net income attributable to Acadia totaled $68.1 million, or $0.74 per diluted share Adjusted income attributable to Acadia totaled $84.1 million, or $0.91 per diluted share Adjusted EBITDA totaled $194.3 million, an increase
Clinics are the Company's first opioid use disorder treatment centers in the Palmetto State Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced the acquisition of three opioid treatment program clinics in South Carolina, which provide treatment for people seeking recovery from opioid use disorder. The clinics – formerly the opioid treatment programs of Recovery Concepts, Recovery Concepts of the Carolina Upstate, and Clear Skye Treatment Center – will be rebranded within Acadia's Comprehensive Treatment Center (CTC) service line as Clinton Comprehensive Treatment Center, Easley Comprehensive Treatment Center, and Ridgeland Comprehensive Treatment Center. These facilities are th
Investor-owned psychiatric hospital chains increasingly operate under nonprofit brands, a strategy that has raised eyebrows among industry analysts and healthcare advocates. Universal Health Services (NYSE:UHS) and Acadia Healthcare Company, Inc. (NASDAQ:ACHC) are prominent players. STAT News’ investigation reveals that a Columbus Police sergeant called for action against Mt. Carmel Behavioral Health, run by Acadia Healthcare, highlighting a series of alarming incidents at the psychiatric hospital. The sergeant’s February letter outlines a disturbing pattern of violence, prompting concerns about patient and staff safety. Over the past six months, the hospital has witnessed over 2
Cantor Fitzgerald analyst Sarah James reiterates Acadia Healthcare Co (NASDAQ:ACHC) with a Neutral and maintains $90 price target.
Cantor Fitzgerald analyst Sarah James reiterates Acadia Healthcare Co (NASDAQ:ACHC) with a Neutral and maintains $90 price target.
4 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)
4 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)
4 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)